🇺🇸 FDA
Patent

US 8937099

N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

granted A61KA61K31/16A61P

Quick answer

US patent 8937099 (N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress) held by SENTIENT LIFESCIENCES, INC. expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTIENT LIFESCIENCES, INC.
Grant date
Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/16, A61P, A61P11/00, A61P11/06